Elekta (EKTAY)
(Delayed Data from OTC)
$4.95 USD
-0.29 (-5.53%)
Updated Sep 25, 2025 02:35 PM ET
3-Hold of 5 3
A Value C Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
EKTAY 4.95 -0.29(-5.53%)
Will EKTAY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for EKTAY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EKTAY
New Strong Sell Stocks for July 24th
Should Value Investors Buy Elekta (EKTAY) Stock?
EKTAY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Investors Undervaluing Elekta (EKTAY) Right Now?
Are Investors Undervaluing Avanos Medical (AVNS) Right Now?
Is Elekta (EKTAY) Stock Undervalued Right Now?
Other News for EKTAY
EU MedTech stocks down as U.S. launches national security probe into imports
Elekta initiated with a Sell at UBS
Elekta initiated with bearish view at UBS, here's why
UBS Initiates a Sell Rating on Elekta AB (0O5H)
Elekta AB (0O5H) Receives a Hold from Deutsche Bank